Huan Yang Selected Research

Atherosclerosis

1/2021	Interleukin-22: a potential therapeutic target in atherosclerosis.
3/2018	Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis.
1/2018	Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.
1/2018	MicroRNA-142-3p Induces Atherosclerosis-Associated Endothelial Cell Apoptosis by Directly Targeting Rictor.
5/2017	MicroRNA-150 targets ELK1 and modulates the apoptosis induced by ox-LDL in endothelial cells.
10/2015	High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
7/2015	MicroRNA-221/222 regulate ox-LDL-induced endothelial apoptosis via Ets-1/p21 inhibition.
3/2015	MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.
8/2012	MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis.
6/2011	MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huan Yang Research Topics

Disease

78	Neoplasms (Cancer) 08/2022 - 01/2003
72	Inflammation (Inflammations) 04/2022 - 03/2002
45	Sepsis (Septicemia) 01/2022 - 01/2002
37	Myasthenia Gravis 06/2022 - 04/2002
23	Infections 01/2022 - 09/2002
19	Endotoxemia 10/2018 - 01/2002
16	COVID-19 04/2022 - 01/2020
14	Neoplasm Metastasis (Metastasis) 05/2022 - 11/2006
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2009
13	Pain (Aches) 07/2022 - 02/2011
13	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 07/2019 - 07/2002
12	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2008
11	Necrosis 08/2021 - 01/2003
10	Breast Neoplasms (Breast Cancer) 05/2022 - 09/2007
10	Atherosclerosis 01/2021 - 06/2011
9	Ischemia 01/2022 - 04/2005
8	Carcinogenesis 01/2021 - 08/2009
7	Pneumonia (Pneumonitis) 08/2022 - 10/2005
7	Atopic Dermatitis (Atopic Eczema) 01/2022 - 07/2017
7	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 11/2014
7	Lung Injury 12/2020 - 04/2003
7	Acute Lung Injury 06/2014 - 01/2002
6	Neuroinflammatory Diseases 02/2022 - 11/2017
6	Hypoxia (Hypoxemia) 01/2022 - 01/2012
6	Brain Ischemia (Cerebral Ischemia) 12/2021 - 11/2008
6	Arthritis (Polyarthritis) 10/2021 - 12/2002
6	Wounds and Injuries (Trauma) 01/2021 - 06/2002
6	Hyperoxia 12/2020 - 03/2013
6	Squamous Cell Carcinoma of Head and Neck 01/2011 - 07/2002
5	Fever (Fevers) 08/2022 - 07/2005
5	Cytokine Release Syndrome 04/2022 - 12/2020
5	Fibrosis (Cirrhosis) 04/2022 - 11/2017
5	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 01/2014
5	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 04/2011
5	Hemorrhage 01/2021 - 02/2005
5	Endometriosis 01/2021 - 04/2012
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2014
4	Multiple Sclerosis 02/2022 - 09/2014
4	Asthma (Bronchial Asthma) 01/2022 - 01/2013
4	Abdominal Aortic Aneurysm 01/2022 - 01/2020
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2003
4	Ischemic Stroke 01/2022 - 12/2014
4	Melanoma (Melanoma, Malignant) 01/2022 - 08/2012
4	Hypertension (High Blood Pressure) 10/2021 - 08/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2009
4	Body Weight (Weight, Body) 01/2021 - 02/2005

Drug/Important Bio-Agent (IBA)

75	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2002
66	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2002
36	CytokinesIBA 07/2022 - 05/2002
31	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2007
21	AntibodiesIBA 01/2022 - 01/2002
16	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
16	MicroRNAs (MicroRNA)IBA 02/2021 - 11/2011
15	Biological ProductsIBA 01/2020 - 01/2010
15	EndotoxinsIBA 10/2018 - 03/2002
13	Therapeutic UsesIBA 06/2022 - 04/2005
13	Cholinergic ReceptorsIBA 01/2020 - 04/2002
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 03/2002
10	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 01/2003
9	Peptides (Polypeptides)IBA 01/2021 - 04/2002
8	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2004
8	Interleukin-6 (Interleukin 6)IBA 07/2022 - 05/2002
8	LipopolysaccharidesIBA 04/2022 - 12/2007
8	Receptor for Advanced Glycation End ProductsIBA 11/2019 - 11/2008
8	Interleukin-2 (IL2)IBA 07/2019 - 04/2002
7	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2013
7	Immunoglobulin G (IgG)IBA 01/2021 - 04/2002
7	LipidsIBA 01/2021 - 01/2003
7	Messenger RNA (mRNA)IBA 01/2020 - 07/2010
7	LigandsIBA 01/2019 - 05/2007
6	Long Noncoding RNAIBA 08/2022 - 03/2015
6	Hormones (Hormone)IBA 01/2022 - 01/2018
6	VaccinesIBA 01/2022 - 02/2013
6	Toll-Like Receptor 4IBA 11/2021 - 09/2007
6	AntigensIBA 10/2021 - 09/2007
6	InterleukinsIBA 01/2021 - 07/2002
6	Hemoglobins (Hemoglobin)IBA 11/2016 - 06/2002
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014 - 03/2009
5	InflammasomesIBA 01/2022 - 08/2012
5	Transcription Factors (Transcription Factor)IBA 03/2021 - 01/2012
5	AutoantibodiesIBA 02/2021 - 01/2019
5	CateninsIBA 10/2020 - 10/2016
5	EnzymesIBA 01/2019 - 02/2003
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2022 - 06/2014
4	AlbuminsIBA 01/2022 - 11/2010
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 03/2002
4	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 05/2020
4	Oxygen (Dioxygen)IBA 12/2021 - 03/2013
4	Adenosine Triphosphate (ATP)IBA 09/2021 - 08/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 05/2007
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2020

Therapy/Procedure

57	Therapeutics 04/2022 - 02/2003
9	Immunotherapy 01/2022 - 01/2019
7	Ligation 01/2020 - 02/2006
6	Punctures 01/2017 - 02/2006
5	Artificial Respiration (Mechanical Ventilation) 01/2021 - 08/2009
4	Radiotherapy 01/2022 - 02/2003
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2007
4	Lasers (Laser) 01/2021 - 08/2009